Axinn is pleased to represent McKesson Corporation (NYSE: MCK), a leading, diversified health care services company, as lead antitrust counsel on its acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for approximately $2.49 billion in cash, which will represent approximately 70% ownership. Announced on August 26, the Core Ventures transaction is part of McKesson’s efforts to advance community-based oncology care, seeking to bring advanced treatments and improved outcomes to patients, while also reducing the overall cost of care. Core Ventures was established by Florida Cancer Specialists (FCS), a leading physician-owned community oncology practice, and Core Ventures serves as its exclusive provider of non-clinical business and other administrative services. FCS will join McKesson’s The U.S. Oncology Network, a leading oncology organization, dedicated to advancing local and affordable cancer care and better patient outcomes.

Axinn is pleased to be representing Choice Hotels International, Inc. (NYSE: CHH) on the antitrust aspects of its proposed acquisition of all outstanding shares of Wyndham Hotels & Resorts, Inc. (NYSE: WH). The Axinn team is led by Mike Keeley, Kail Jethmalani, Craig Minerva, and Michael O’Mara.